Adoptive T-cell therapy is an effective strategy for cancer immunotherapy. However, 
(TAA)-loaded antigen-presenting cells, and then expanded TILs are infused into patients. Gene transducing technologies have also recently been applied to adoptive T cell therapy. Artificially designed T-cell receptor (TCR) or chimeric antigen receptor (CAR) against TAA and CAR target antigens are transduced into patients' T cells with TCR stimulation and expansion. 4 As in TIL therapy, these transduced T cells are also re-infused into patients to attack tumor cells. However, the therapeutic effects of tumor-specific T cell transfer have been limited because infused T cells frequently lose functionality after transplantation. 1, 5 The TAA-specific T cells become exhausted and dysfunctional in the tumor microenvironment and through the T cell culture procedures. 6, 7 Therefore, restoration and enforcement of T cell function and persistency could improve long-term outcomes for cancer patients. (Table 1) . [16] [17] [18] [19] [20] We have established a novel two-step culture system for T SCM induction, which is constituted by a "prime" step and an "induction" step, and have named the induced-T SCM "induced-T SCM (iT SCM )" cells. 12 In this paper, we describe a detailed methodology of iT SCM generation and report optimal conditions of priming and cytokine treatment. We also investigate the antitumor efficacy of human iT SCM cells in a humanized mouse model.
| MATERIALS AND METHODS

| OP9-hDLL1 cell coculture
Human T cells were activated using the methods mentioned above. 
| Statistics
Statistical analysis was carried out using Student's t-test, one-way ANOVA and a long-rank test, using GraphPad Prism version 6.05 software (GraphPad Software, La Jolla, CA, USA). The variance among the groups was estimated using the F-test, and P-values <.05
were considered statistically significant. All data are presented as the mean AE SEM. Mice were randomly assigned to experimental groups.
The investigators were not blinded to allocation during experiments and outcome assessment.
Further information regarding materials and methods is included in Tables S1,S2 .
T A B L E 1 Recently reported methods for stem cell memory T cell generation from na€ ıve T cells step. Next, cell trace dye-diluted activated T cells were purified by a cell sorter and were then transferred onto and cocultured with DLL1-expressing OP9 stromal cells (OP9-hDLL1) for 11 days in the "induction" step ( Figure 1B Figure 2B ). In addition, the number of T EMderived CD8a + T cells was not changed or was only slightly reduced, whereas that of T CM -derived CD8a + T cells was significantly increased Table 2 . The iT SCM cells from LCL and CD3/ CD28 bead-activated T cells were generated in greater number than from MART-1-specific T cells. These data indicate that activated T cells by any TCR stimulating procedure can be converted into iT SCM cells.
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| Cytokine effects in the prime step on iT SCM generation
Interleukin-15 and IL-21 have been reported to enhance T SCM inducing efficiency. 17, 21 To investigate T cell stimulating and homeostatic cytokine effects in the prime step, we cocultured T cells with Table 3 ). The absence of cytokines and the presence of IL-7 and IL-15 in the prime step could more efficiently convert into iT SCM cells with a higher degree of proliferation than other T cells.
| Conversion of long-term cultured T cells into iT SCM generation
In conventional T-cell therapy, T cells are repeatedly stimulated for a long period to be expanded before infusion into patients; however,
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Start of T cell prime such long-term TCR stimulation leads to T cell exhaustion or anergy. 27 We assessed whether long-term culture of T cells has any effects on iT SCM generation. We first cocultured carboxyfluorescein succinimidyl ester (CFSE)-labelled T cells with autologous LCL in the presence of IL-7 or IL-15. Seven days after the coculture, we isolated EBV-specific T cells and then restimulated these cells by coculture with LCL for an additional 21 days ( Figure S2A,B) . Long-term culture strongly induced terminal differentiation of EBV-specific T cells, whereas several T cells maintained T SCM and T CM phenotypes, as shown in Figure S2 (C). Cytokine-depleted conditions did not allow T cells to survive for 2 weeks (data no shown). We next isolated each memory T cell subset and then cocultured them with OP9-hDLL1 cells. Both IL-7-and IL-15-stimulated T SCM cells completely retained T SCM cell phenotypes and showed a 0.8-fold increase in cell counts after coculture with OP9-hDLL1 cells ( Figure S2D , Table 4 ).
Partial conversion into iT SCM cells and 0.8-fold increases in the number of cells were observed in IL-7-stimulated T CM cells and IL-7-or
IL-15-stimulated T EMRA cells ( Figure S2D , Table 4 ). Small percentage of interleukin-15-stimulated T CM cells and T EM cells were converted into iT SCM cells ( Figure S2D , Table 4 ). These data indicate that the presence of IL-7 in long-term priming could efficiently generate iT SCM cells from T SCM , T CM , and T EMRA cells.
| Cytokine effects in the induction step on iT SCM generation
To assess cytokine effects in the induction step, we next cocultured T cells with autologous LCL for 7 days, and EBV-specific T 
| Application of human iT SCM cells for cancer immunotherapy
The iT SCM cells showed strong proliferation following recall response and long-term persistence after adoptive transfer. 29 Thus, we inves- 
